{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:15:57Z","timestamp":1762521357176},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,3,11]],"date-time":"2010-03-11T00:00:00Z","timestamp":1268265600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s10549-010-0819-x","type":"journal-article","created":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T07:32:09Z","timestamp":1268206329000},"page":"35-42","source":"Crossref","is-referenced-by-count":24,"title":["Estrogen levels act as a rheostat on p53 levels and modulate p53-dependent responses in breast cancer cell lines"],"prefix":"10.1007","volume":"125","author":[{"given":"Lynnette","family":"Fern\u00e1ndez-Cuesta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh","family":"Anaganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Hainaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magali","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,11]]},"reference":[{"key":"819_CR1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/351453a0","volume":"351","author":"AJ Levine","year":"1991","unstructured":"Levine AJ, Momand J, Finlay CA (1991) The p53 tumour suppressor gene. Nature 351:453\u2013456","journal-title":"Nature"},{"key":"819_CR2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0065-230X(08)60785-X","volume":"77","author":"P Hainaut","year":"2000","unstructured":"Hainaut P, Hollstein M (2000) p53 and human cancer: the first ten thousand mutations. Adv Cancer Res 77:81\u2013137","journal-title":"Adv Cancer Res"},{"key":"819_CR3","unstructured":"Olivier M, Hainaut P, Borresen-Dale A (2005) Prognostic and predictive value of TP53 mutations in human cancer. In: Hainaut P, Wiman K (eds) 25\u00a0years of p53 research. Springer, pp 321\u2013338"},{"key":"819_CR4","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00026.2006","volume":"87","author":"N Heldring","year":"2007","unstructured":"Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Strom A, Treuter E, Warner M, Gustafsson JA (2007) Estrogen receptors: how do they signal and what are their targets. Physiol Rev 87:905\u2013931","journal-title":"Physiol Rev"},{"key":"819_CR5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/jcp.21253","volume":"213","author":"BJ Cheskis","year":"2007","unstructured":"Cheskis BJ, Greger JG, Nagpal S, Freedman LP (2007) Signaling by estrogens. J Cell Physiol 213:610\u2013617","journal-title":"J Cell Physiol"},{"key":"819_CR6","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.steroids.2008.11.020","volume":"74","author":"RJ Santen","year":"2009","unstructured":"Santen RJ, Fan P, Zhang Z, Bao Y, Song RX, Yue W (2009) Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer cells. Steroids 74:586\u2013594","journal-title":"Steroids"},{"key":"819_CR7","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1158\/0008-5472.CAN-07-0967","volume":"67","author":"V Duong","year":"2007","unstructured":"Duong V, Boulle N, Daujat S, Chauvet J, Bonnet S, Neel H, Cavailles V (2007) Differential regulation of estrogen receptor alpha turnover and transactivation by Mdm2 and stress-inducing agents. Cancer Res 67:5513\u20135521","journal-title":"Cancer Res"},{"key":"819_CR8","first-page":"1810","volume":"60","author":"G Liu","year":"2000","unstructured":"Liu G, Schwartz JA, Brooks SC (2000) Estrogen receptor protects p53 from deactivation by human double minute-2. Cancer Res 60:1810\u20131814","journal-title":"Cancer Res"},{"key":"819_CR9","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/sj.onc.1202398","volume":"18","author":"C Hurd","year":"1999","unstructured":"Hurd C, Dinda S, Khattree N, Moudgil VK (1999) Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells. Oncogene 18:1067\u20131072","journal-title":"Oncogene"},{"key":"819_CR10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0960-0760(00)00151-5","volume":"76","author":"VK Moudgil","year":"2001","unstructured":"Moudgil VK, Dinda S, Khattree N, Jhanwar S, Alban P, Hurd C (2001) Hormonal regulation of tumor suppressor proteins in breast cancer cells. J Steroid Biochem Mol Biol 76:105\u2013117","journal-title":"J Steroid Biochem Mol Biol"},{"key":"819_CR11","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1158\/0008-5472.CAN-08-3628","volume":"69","author":"SH Shirley","year":"2009","unstructured":"Shirley SH, Rundhaug JE, Tian J, Cullinan-Ammann N, Lambertz I, Conti CJ, Fuchs-Young R (2009) Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells. Cancer Res 69:3405\u20133414","journal-title":"Cancer Res"},{"key":"819_CR12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1677\/joe.0.1800497","volume":"180","author":"SV Angeloni","year":"2004","unstructured":"Angeloni SV, Martin MB, Garcia-Morales P, Castro-Galache MD, Ferragut JA, Saceda M (2004) Regulation of estrogen receptor-alpha expression by the tumor suppressor gene p53 in MCF-7 cells. J Endocrinol 180:497\u2013504","journal-title":"J Endocrinol"},{"key":"819_CR13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/bbrc.1999.1525","volume":"264","author":"G Liu","year":"1999","unstructured":"Liu G, Schwartz JA, Brooks SC (1999) p53 down-regulates ER-responsive genes by interfering with the binding of ER to ERE. Biochem Biophys Res Commun 264:359\u2013364","journal-title":"Biochem Biophys Res Commun"},{"key":"819_CR14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1593\/neo.05256","volume":"7","author":"BD Jeffy","year":"2005","unstructured":"Jeffy BD, Hockings JK, Kemp MQ, Morgan SS, Hager JA, Beliakoff J, Whitesell LJ, Bowden GT, Romagnolo DF (2005) An estrogen receptor-alpha\/p300 complex activates the BRCA-1 promoter at an AP-1 site that binds Jun\/Fos transcription factors: repressive effects of p53 on BRCA-1 transcription. Neoplasia 7:873\u2013882","journal-title":"Neoplasia"},{"key":"819_CR15","doi-asserted-by":"crossref","first-page":"29671","DOI":"10.1074\/jbc.M802785200","volume":"283","author":"W Jin","year":"2008","unstructured":"Jin W, Chen Y, Di GH, Miron P, Hou YF, Gao H, Shao ZM (2008) Estrogen Receptor (ER) beta or p53 attenuates ER{alpha}-mediated transcriptional activation on the BRCA2 promoter. J Biol Chem 283:29671\u201329680","journal-title":"J Biol Chem"},{"key":"819_CR16","doi-asserted-by":"crossref","first-page":"9837","DOI":"10.1074\/jbc.C600001200","volume":"281","author":"W Liu","year":"2006","unstructured":"Liu W, Konduri SD, Bansal S, Nayak BK, Rajasekaran SA, Karuppayil SM, Rajasekaran AK, Das GM (2006) Estrogen receptor-alpha binds p53 tumor suppressor protein directly and represses its function. J Biol Chem 281:9837\u20139840","journal-title":"J Biol Chem"},{"key":"819_CR17","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1038\/sj.onc.1208595","volume":"24","author":"SA Lewandowski","year":"2005","unstructured":"Lewandowski SA, Thiery J, Jalil A, Leclercq G, Szczylik C, Chouaib S (2005) Opposite effects of estrogen receptors alpha and beta on MCF-7 sensitivity to the cytotoxic action of TNF and p53 activity. Oncogene 24:4789\u20134798","journal-title":"Oncogene"},{"key":"819_CR18","first-page":"2594","volume":"60","author":"AM Molinari","year":"2000","unstructured":"Molinari AM, Bontempo P, Schiavone EM, Tortora V, Verdicchio MA, Napolitano M, Nola E, Moncharmont B, Medici N, Nigro V, Armetta I, Abbondanza C, Puca GA (2000) Estradiol induces functional inactivation of p53 by intracellular redistribution. Cancer Res 60:2594\u20132597","journal-title":"Cancer Res"},{"key":"819_CR19","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1128\/MCB.01742-06","volume":"27","author":"D Menendez","year":"2007","unstructured":"Menendez D, Inga A, Snipe J, Krysiak O, Schonfelder G, Resnick MA (2007) A single-nucleotide polymorphism in a half-binding site creates p53 and estrogen receptor control of vascular endothelial growth factor receptor 1. Mol Cell Biol 27:2590\u20132600","journal-title":"Mol Cell Biol"},{"key":"819_CR20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00001622-199511000-00013","volume":"7","author":"SW Lowe","year":"1995","unstructured":"Lowe SW (1995) Cancer therapy and p53. Curr Opin Oncol 7:547\u2013553","journal-title":"Curr Opin Oncol"},{"key":"819_CR21","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1078-0432.CCR-05-1029","volume":"12","author":"M Olivier","year":"2006","unstructured":"Olivier M, Langerod A, Carrieri P, Bergh J, Klaar S, Eyfjord J, Theillet C, Rodriguez C, Lidereau R, Bieche I, Varley J, Bignon Y, Uhrhammer N, Winqvist R, Jukkola-Vuorinen A, Niederacher D, Kato S, Ishioka C, Hainaut P, Borresen-Dale AL (2006) The clinical value of somatic TP53 gene mutations in 1, 794 patients with breast cancer. Clin Cancer Res 12:1157\u20131167","journal-title":"Clin Cancer Res"},{"key":"819_CR22","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1128\/MCB.12.12.5581","volume":"12","author":"E Shaulian","year":"1992","unstructured":"Shaulian E, Zauberman A, Ginsberg D, Oren M (1992) Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol Cell Biol 12:5581\u20135592","journal-title":"Mol Cell Biol"},{"key":"819_CR23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1023\/A:1006960021281","volume":"26","author":"C Salvat","year":"1999","unstructured":"Salvat C, Aquaviva C, Jariel-Encontre I, Ferrara P, Pariat M, Steff AM, Carillo S, Piechaczyk M (1999) Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo? Mol Biol Rep 26:45\u201351","journal-title":"Mol Biol Rep"},{"key":"819_CR24","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1073\/pnas.96.5.1858","volume":"96","author":"Z Nawaz","year":"1999","unstructured":"Nawaz Z, Lonard DM, Dennis AP, Smith CL, O\u2019Malley BW (1999) Proteasome-dependent degradation of the human estrogen receptor. Proc Natl Acad Sci USA 96:1858\u20131862","journal-title":"Proc Natl Acad Sci USA"},{"key":"819_CR25","doi-asserted-by":"crossref","first-page":"35684","DOI":"10.1074\/jbc.M101097200","volume":"276","author":"AL Wijayaratne","year":"2001","unstructured":"Wijayaratne AL, McDonnell DP (2001) The human estrogen receptor-alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators. J Biol Chem 276:35684\u201335692","journal-title":"J Biol Chem"},{"key":"819_CR26","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ncb1101-973","volume":"3","author":"BP Zhou","year":"2001","unstructured":"Zhou BP, Liao Y, Xia W, Zou Y, Spohn B, Hung MC (2001) HER-2\/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol 3:973\u2013982","journal-title":"Nat Cell Biol"},{"key":"819_CR27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/387299a0","volume":"387","author":"MH Kubbutat","year":"1997","unstructured":"Kubbutat MH, Jones SN, Vousden KH (1997) Regulation of p53 stability by Mdm2. Nature 387:299\u2013303","journal-title":"Nature"},{"key":"819_CR28","first-page":"447S","volume":"9","author":"R Schiff","year":"2003","unstructured":"Schiff R, Massarweh S, Shou J, Osborne CK (2003) Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response. Clin Cancer Res 9:447S\u2013454S","journal-title":"Clin Cancer Res"},{"key":"819_CR29","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.1038\/sj.onc.1208787","volume":"24","author":"KA Becker","year":"2005","unstructured":"Becker KA, Lu S, Dickinson ES, Dunphy KA, Mathews L, Schneider SS, Jerry DJ (2005) Estrogen and progesterone regulate radiation-induced p53 activity in mammary epithelium through TGF-beta-dependent pathways. Oncogene 24:6345\u20136353","journal-title":"Oncogene"},{"key":"819_CR30","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1186\/bcr2094","volume":"10","author":"KA Dunphy","year":"2008","unstructured":"Dunphy KA, Blackburn AC, Yan H, O\u2019Connell LR, Jerry DJ (2008) Estrogen and progesterone induce persistent increases in p53-dependent apoptosis and suppress mammary tumors in BALB\/c-Trp53\u00a0\u00b1\u00a0mice. Breast Cancer Res 10:R43","journal-title":"Breast Cancer Res"},{"key":"819_CR31","first-page":"1439","volume":"2","author":"C Guillot","year":"1996","unstructured":"Guillot C, Falette N, Courtois S, Voeltzel T, Garcia E, Ozturk M, Puisieux A (1996) Alteration of p53 damage response by tamoxifen treatment. Clin Cancer Res 2:1439\u20131444","journal-title":"Clin Cancer Res"},{"key":"819_CR32","first-page":"217","volume":"100","author":"AS Adhikari","year":"2009","unstructured":"Adhikari AS, Iwakuma T (2009) Mutant p53 gain of oncogenic function: in vivo evidence, mechanism of action and its clinical implications. Fukuoka Igaku Zasshi 100:217\u2013228","journal-title":"Fukuoka Igaku Zasshi"},{"key":"819_CR33","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc2693","volume":"9","author":"R Brosh","year":"2009","unstructured":"Brosh R, Rotter V (2009) When mutants gain new powers: news from the mutant p53 field. Nat Rev Cancer 9:701\u2013713","journal-title":"Nat Rev Cancer"},{"key":"819_CR34","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1101\/gad.1662908","volume":"22","author":"T Terzian","year":"2008","unstructured":"Terzian T, Suh YA, Iwakuma T, Post SM, Neumann M, Lang GA, Van Pelt CS, Lozano G (2008) The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss. Genes Dev 22:1337\u20131344","journal-title":"Genes Dev"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-0819-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-010-0819-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-0819-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:32:29Z","timestamp":1559233949000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-010-0819-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,11]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["819"],"URL":"https:\/\/doi.org\/10.1007\/s10549-010-0819-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,11]]}}}